Related Experiment Videos
[Polymyalgia rheumatica: myalgic syndrome or occult vasculitis?]
1Rheumaklinik Bad Bramstedt and Poliklinik für Rheumatologie, Universitätsklinikum Schleswig-Holstein, Campus Lübeck. hellmich@rheuma-zentrum.de
Der Internist
|September 10, 2005
Summary
Polymyalgia rheumatica (PMR) is an inflammatory condition causing muscle pain, primarily in older adults. It often co-occurs with giant cell arteritis (GCA) and responds well to corticosteroid treatment.
Area of Science:
- Rheumatology
- Immunology
- Internal Medicine
Context:
- Polymyalgia rheumatica (PMR) is a chronic inflammatory disorder of unknown cause.
- It characteristically affects individuals over 50, presenting with symmetric shoulder and pelvic girdle myalgias.
- PMR is frequently associated with giant cell arteritis (GCA), a condition affecting large arteries.
Purpose:
- To summarize the key clinical features, diagnostic considerations, and management strategies for Polymyalgia Rheumatica.
- To highlight the relationship between PMR and Giant Cell Arteritis (GCA).
- To discuss the role of imaging and laboratory findings in diagnosing and monitoring PMR.
Summary:
- PMR typically manifests with rapid onset of muscle pain in the girdles, elevated inflammatory markers (ESR, CRP), and synovitis/bursitis.
- While GCA diagnosis is confirmed by temporal artery biopsy, PMR lacks specific autoantibodies, relying on clinical presentation and response to treatment.
- Advanced imaging suggests subclinical GCA, like aortitis, may be more prevalent in PMR patients than previously thought.
Impact:
- Early diagnosis and appropriate management of PMR can prevent long-term complications and improve patient quality of life.
- Understanding the PMR-GCA association aids in timely diagnosis and treatment of potentially sight-threatening GCA.
- Corticosteroid therapy is the mainstay for PMR, often requiring long-term treatment (≥2 years) and potentially steroid-sparing agents like methotrexate to mitigate adverse effects.